J Clin Aesthet Dermatol. 2020;13(7):32–35 by Fathia M. Khattab, MD Dr. Khattab is with the Faculty of Medicine, Zagazig University in Zagazig, Egypt. FUNDING: No funding was provided for this study. DISCLOSURES: The author has no conflicts of interest relevant to the content of this article. ABSTRACT: Background. Botulinum toxin (BTX) A has different biological
A message from the Guest Editor and MauiDerm Program Director, George Martin, MD Dear Colleagues: The 2020 edition of the MauiDerm for Dermatologists meeting had a variety of clinical and scientific data presented, but not just at the podium. A wide range of clinically relevant material was also presented in poster format. For those of
J Clin Aesthet Dermatol. 2020;13(5):44–48 by James Q. Del Rosso, DO, FAAD, FAOCD Dr. Del Rosso is Research Director at JDR Dermatology Research in Las Vegas, Nevada; is with Thomas Dermatology in Las Vegas, Nevada, and is an adjunct clinical professor of dermatology at Touro University Nevada in Henderson, Nevada. FUNDING: No funding was provided
J Clin Aesthet Dermatol. 2019;12(12):28–34 by Corinna E. Psomadakis, MBBS, and George Han, MD Drs. Psomadakis and Han are with the Department of Dermatology, Mount Sinai Medical Center in New York, New York. FUNDING: No funding was provided for this study. DISCLOSURES: Dr. Han has consulted for Regeneron, Sanofi Genzyme, Pfizer, Sun, and Janssen. Dr.
by Alexis B. Lyons, MD; Lauren Moy, MD; Ronald Moy, MD; and Rebecca Tung, MD Dr. Lyons is with the Department of Dermatology at Henry Ford Hospital in Detroit, Michigan. Drs. L. Moy and Tung are with the Department of Dermatology at Loyola University Medical Center in Chicago, Illinois. Dr. R. Moy is with Moy,